Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular DystrophyAngela Lek, Terence R. Flotte, Rebecca Artinian et al.|New England Journal of Medicine|2023Cited by 302
MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene ExpressionJun Xie, Guangping Gao, Qing Xie et al.|Molecular Therapy|2010Cited by 168
Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expressionChristian Mueller, Terence R. Flotte|Journal of Clinical Investigation|2013Cited by 160
Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivatorAngela Lek, Terence R. Flotte, Brenda Wong et al.|medRxiv|2023Cited by 34